DJIA 17,523.90 83.31 0.48%
NASDAQ 5,045.68 5.91 0.12%
S&P 500 2,080.20 12.56 0.61%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

171.50 5.96 (3.60%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $171.52 3.61%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $166.12
Previous Close $165.54
Daily Range $166.12 - $172.34
52-Week Range $121.66 - $173.60
Market Cap $130.4B
P/E Ratio 22.34
Dividend (Yield) $3.16 (1.9%)
Ex-Dividend Date
Dividend Pay Date
05/12/15
06/05/15
Volume 3,239,074
Average Daily Volume 3,020,061
Current FY EPS $9.58

Sector

Healthcare

Industry

Drug Makers

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary Rss Feed

3 Questions to Ask Ahead of Amgen's Second-Quarter Earnings Release

The next big catalyst is right around the corner for Amgen. Find out what important questions you should be asking as Amgen readies to report its second-quarter earnings results on July 30.

Nasdaq 100 Movers: BIDU, AMGN

Trade-Ideas: Amgen (AMGN) Is Today's Strong On High Relative Volume Stock

Benzinga's M&A Chatter for Monday July 27, 2015

Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog

Regeneron Pharmaceuticals and Sanofi Grab a Blockbuster FDA Approval

The FDA has given the nod to the sale of Praluent, the first of a new class of cholesterol lowering medications, and a blockbuster opportunity for the company's.

Stock Market News for July 27, 2015 - Market News

A Big Day For Biotech And It's Not Going So Well

Nasdaq 100 Movers: MYL, BIIB

Premarket Biotech Digest: Gilead Earnings Tomorrow, Praluent, Other Approvals

See More AMGN News...

AMGN's Top Competitors

AMGN $171.50 (3.60%)
Current stock: AMGN
GILD $111.30 (0.69%)
Current stock: GILD
CELG $134.12 (1.18%)
Current stock: CELG
$0.00 (0.00%)
Current stock: